logo

Men with persistently elevated serum PSA levels after a negative first TRUS-guided systematic prostate biopsy (SBx) represent a great diagnostic challenge. To meet this challenge, [...]
Using a large comprehensive population-based cohort from Canada, Doiron et al. [1] present an in-depth analysis of risk factors and timing of venous thromboembolism (VTE) after rad[...]
Several risk calculators (RCs) have been developed to predict prostate cancer (PCa) diagnosis at prostate biopsy. These multivariable tools have constantly been shown to be superio[...]
Infertility affects 15% of couples, with male factor infertility influencing half of such couples [1]. Multiple environmental risk factors for male infertility have been identified[...]
An increasingly ageing and frail population undergoing cystectomy and urinary diversion has rekindled interest in urinary diversions with a lower risk of peri-operative complicatio[...]
There have been numerous advances in the management of prostate cancer. Developments in imaging, surgical and radiotherapy technology, and pathological grading, have led to improve[...]
For the first time, Storebjerg et al. [1] describe the prevalence of the HOXB13 G84E mutation in a Danish population and its association with prostate cancer risk and features indi[...]
Introduction In the last few years there have been concerted attempts at using the power of the immune system as an effective treatment option for cancer. This has become possible [...]
In a study in this issue of BJUI, Aghazadeh et al. [1] were able to show that there was a significant relationship between simulated robotic performance and robotic clinical perfor[...]
One of the great triumphs in Urology is the transition of prostate cancer surgery from a universally morbid operation to one that now focuses on postoperative quality of life. This[...]